Invesco’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Invesco’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,449	Closed	-$435K	–	4042
2024 Q1	$435K	Sell	12,449 -37,637	-75%	-$1.37M	﹤0.01%	3393
2023 Q4	$1.9M	Buy	50,086 +31,076	+163%	+$666K	﹤0.01%	2629
2023 Q3	$349K	Sell	19,010 -40,124	-68%	-$840K	﹤0.01%	3376
2023 Q2	$1.54M	Buy	59,134 +44,360	+300%	+$1.04M	﹤0.01%	2722
2023 Q1	$279K	Buy	14,774 +622	+4%	+$14.5K	﹤0.01%	3522
2022 Q4	$349K	Sell	14,152 -255	-2%	-$7.5K	﹤0.01%	3446
2022 Q3	$259K	Buy	14,407 +2,930	+26%	+$52.8K	﹤0.01%	3584
2022 Q2	$130K	Buy	11,477 +119	+1%	+$1.75K	﹤0.01%	3837
2022 Q1	$253K	Sell	11,358 -40,838	-78%	-$1.04M	﹤0.01%	3705
2021 Q4	$2.28M	Sell	52,196 -7,662	-13%	-$306K	﹤0.01%	2748
2021 Q3	$1.99M	Buy	59,858 +51,357	+604%	+$1.56M	﹤0.01%	2815
2021 Q2	$234K	Buy	+8,501	New	+$177K	﹤0.01%	3732

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Invesco's INBX Position: Q2 2024 in Review

Invesco sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 12,449 shares — an estimated $435K sold.

Invesco first reported a position in INBX in Q2 2021 and held it in 12 quarters. The position peaked at $2.28M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Invesco reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Invesco sold 12,449 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $435K.
Invesco first reported a position in Inhibrx, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
Invesco's Inhibrx, Inc. Common Stock position peaked at $2.28M in Q4 2021.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.